We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

42 hedge funds and large institutions have $112M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

394% more capital invested

Capital invested by funds: $22.7M → $112M (+$89.6M)

91% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 11

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

33% more call options, than puts

Call options by funds: $292K | Put options by funds: $220K

31% more funds holding

Funds holding: 3242 (+10)

14.31% more ownership

Funds ownership: 11.51%25.82% (+14%)

Holders
42
Holders Change
+10
Holders Change %
+31.25%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
21
Increased
10
Reduced
6
Closed
11
Calls
$292K
Puts
$220K
Net Calls
+$72K
Net Calls Change
+$14K
Name Holding Trade Value Shares
Change
Change in
Stake
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$30.3M +$27.1M +7,991,377 New
HA
2
HHLR Advisors
Cayman Islands
$22.6M
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$12.6M +$11.3M +3,338,034 New
Morgan Stanley
4
Morgan Stanley
New York
$8.44M +$7.38M +2,173,745 +3,729%
ACM
5
Ariose Capital Management
Hong Kong
$6.44M +$5.46M +1,607,938 +1,667%
EAM
6
Exome Asset Management
New York
$5.44M +$4.89M +1,439,604 New
SL
7
Siren LLC
Connecticut
$4.41M +$3.96M +1,165,957 New
CS
8
Candriam SCA
Luxembourg
$4.28M
WP
9
Woodline Partners
California
$3.97M +$3.56M +1,050,000 New
PHK
10
Point72 Hong Kong
Hong Kong
$2.12M +$1.91M +561,366 New
SG Americas Securities
11
SG Americas Securities
New York
$1.75M -$1.4M -412,459 -47%
Barclays
12
Barclays
United Kingdom
$1.49M +$1.24M +365,061 +1,202%
State Street
13
State Street
Massachusetts
$1.28M +$1.15M +337,400 New
UBS Group
14
UBS Group
Switzerland
$1.12M +$374K +110,233 +60%
Goldman Sachs
15
Goldman Sachs
New York
$826K +$705K +207,788 +1,945%
Connor, Clark & Lunn Investment Management (CC&L)
16
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$620K +$463K +136,264 +490%
JP Morgan Chase
17
JP Morgan Chase
New York
$568K +$510K +150,164 New
SCM
18
Superstring Capital Management
New York
$529K +$475K +139,886 New
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
$452K -$9.82K -2,893 -2%
AA
20
ALPS Advisors
Colorado
$421K +$378K +111,490 New
LP
21
LMR Partners
United Kingdom
$378K +$339K +100,000 New
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$373K +$137K +40,418 +69%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$292K +$263K +77,348 New
XT
24
XTX Topco
Cayman Islands
$273K +$245K +72,104 New
Renaissance Technologies
25
Renaissance Technologies
New York
$240K -$339 -100 -0.2%

NBP Hedge Fund Activity: Q3 2025 in Review

42 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2025, worth a combined $112M — up 394% from $22.7M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NBP positions and 11 closed out — a net gain of 10 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $27.1M. The largest seller was SG Americas Securities, cutting an estimated $1.4M.

  • 42 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2025, up from 32 in Q2 2025.
  • Funds reported $112M of NovaBridge Biosciences American Depositary Shares stock for Q3 2025, up 394% quarter-over-quarter.
  • 21 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2025 and 11 closed out, a net change of +10 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2025 was Janus Henderson Group, an estimated $27.1M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2025 was SG Americas Securities, an estimated $1.4M sold.

Based on aggregated 13F filings for Q3 2025.